Sofinnova Investments’s Soleno Therapeutics SLNO Stock Holding History

Sofinnova Investments’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-529,300	Closed	-$37.8M	–	77
2025 Q1	$37.8M	Buy	+529,300	New	+$25.8M	2.47%	12
2024 Q4	–	Sell	-300,000	Closed	-$15.1M	–	75
2024 Q3	$15.1M	Buy	+300,000	New	+$14.4M	1.2%	22

Sofinnova Investments's SLNO Position: Q2 2026 in Review

Sofinnova Investments sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 14,689 shares — an estimated $492K sold.

Sofinnova Investments first reported a position in SLNO in Q4 2023 and held it in 10 quarters. The position peaked at $34.8M in Q2 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Sofinnova Investments reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Sofinnova Investments sold 14,689 Soleno Therapeutics shares in Q2 2026, an estimated $492K.
Sofinnova Investments first reported a position in Soleno Therapeutics in Q4 2023 and held it in 10 quarters.
Sofinnova Investments's Soleno Therapeutics position peaked at $34.8M in Q2 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Sofinnova Investments's 13F filing for Q2 2026, filed 14 Aug 2026.